MCC Spirit of Collaboration Awards - 2014

2014 Spirit of Collaboratin Awards

  • Enhancing Breast Cancer Genomics Best Practices and Policies in the State of Michigan (2011-2014)
    Collaborating Partners: Centers for Disease Control and Prevention (CDC), Michigan Department of Community Health (MDCH), academia, insurers, health systems, health plans, Michigan Cancer Genetics Alliance.
    Project description/outcomes: This CDC-MDCH collaboration involved numerous national, state, and local partners and utilized multi-faceted comprehensive cancer genomics programs to assure appropriate translation of health plan policy change, provider education, and surveillance
    to promote best BRCA practices. The ultimate impact of the project is a reduction in early breast and ovarian cancer deaths to Michigan residents resulting from appropriate use of cancer genetic and related clinical services in persons at risk. Numerous outcomes were documented
    including: recognizing 14 of 25 health plans in Michigan for written BRCA counseling and testing policies aligned with the 2005 USPSTF recommendation (from baseline of 4 health plans in 2009) – these health plans provide coverage to over 7.5 million Michigan residents; found
    78.9% of those seen for BRCA counseling by a Michigan board-certified genetics professional and 78.7% of those with testing after counseling in 2013 were a member of one of these 14 health plans; reduced the barrier of inadequate insurance coverage for BRCA testing for patients seen for counseling patients by a board-certified genetic professional from 23.8% in 2009 to 11% in 2013.
  • Jewish Women's Health Project
    Collaborating Partners
    : Council of Orthodox Rabbis, Women’s Orthodox League, The Jewish Fund, Jewish Family Service, The Jewish Community Center of Oak Park, and Kids Kicking Cancer.
    Project description/outcomes: Genetic research has documented a high prevalence of the BRCA I and II and APC genes among Ashkenazi (i.e. European) Jewish women. Mutations in these genes place carriers at a significantly greater risk for breast, ovarian, pancreatic,
    colorectal, and other cancers. One group in which this genetic risk may be particularly high is Orthodox Jews – an insular and religious high cancer risk, yet understudied, community. In a pilot study using census tract and Detroit Surveillance Epidemiology and End Results (SEER)
    data, Principal Investigator Dr. Rifky Tkatch and her colleagues found that Orthodox Jewish women have higher rates of breast cancer than the general population. The purpose of the project is to use a community based participatory research approach to address the specific cancer needs and issues among Orthodox Jewish women and to develop and pilot a cancer education program. In the summer of 2013 a community cancer-related health survey was developed. 450 women were randomly selected and received the survey in the mail. 260 women returned the anonymous surveys. The education program is a religious based cancerrelated health education program. Collaborating partners were involved in the development of
    this program and the program is being delivered by community members. In the first four months, over 100 women contacted the research staff to participate. In addition, collaborating partners have assisted in recruitment to the program. To date, 60 women have completed the education program with incredibly positive feedback.
  • Michigan Oncology Quality Consortium
    Collaborating partners: Michigan Oncology Quality Consortium (MOQC), Michigan Cancer Consortium (MCC), Michigan Department of Community Health (MDCH).
    Project description/outcomes: MOQC, a Blue Cross Blue Shield of Michigan sponsored quality collaborative, works to improve the care of cancer patients in Michigan using data gathered as part of the national QOPI (Quality Oncology Practice Initiative) program. MOQC identified a significant quality gap in terms of the lack of cessation counseling/referrals for cancer patients identified as tobacco users. MCC and the MDCH Tobacco Control Program worked to reduce barriers to referrals by funding free counseling and Nicotine Replacement Therapy (NRT) for cancer patients using the Quitline service. The MCC, MDCH, and MOQC also partnered on a learning collaborative to improve cancer patient access to tobacco cessation services. Eighteen oncology practices/clinics (63 physicians) participated in 3 learning sessions to redesign care and identify best practices (this work has now spread to over 30 locations in Michigan and is one of the largest multi-site tobacco cessation programs for cancer patients in the country). A lean problem solving approach was used that included standard workflow scripts and visual management tools to support frontline staff in identifying all cancer patients who use tobacco and referring them to the Quitline. Between May and December of 2013 a total of 694 cancer patients were referred for cessation support and at least 1 contact attempt was made for 686 patients. A total of 308 patients (45%) were successfully contacted by the Quitline; only 3% were ineligible to participate and 26% declined participation. Whereas total Michigan Quitline referrals increased by an average of 40% each month in this period, nonMOQC patient referrals increased from 62 per month to 80-123 per month in the subsequent months representing an average of 43% of all Michigan Quitline referrals. Tobacco assessment rates for cancer patients were maintained above 95% and an average of 61% of eligible cancer patients were referred to the Quitline – a four-fold increase from the baseline referral rate of 15%. As of April 2014, over 1000 patients had been referred to Quitline.
  • Personal Action Towards Health (PATH) – Redefining You: The New Normal After Cancer
    Collaborating Partners: McLaren Oakland, National Kidney Foundation of Michigan, Michigan Cancer Consortium, Michigan Department of Community Health, and the American Cancer Society.
    Project Description/outcomes: PATH is Michigan’s brand for the Stanford Chronic Disease Self-Management Program, an evidence-based 6-week workshop that meets once a week for 2.5 hours. The Redefining You: The New Normal After Cancer PATH program sought to empower cancer survivors to adopt healthier lifestyles. The workshops were held in convenient, easily accessed community locations in Oakland, Lapeer, and Macomb County and were offered for free. Of 115 enrollees, a total of 95 participants attended at least 4 of the 6 sessions for a completion rate of 83%. In a post-workshop survey, all 95 participants stated they would use at least one of the self-management tools learned during PATH after the workshop ended.
    The top 5 tools participants mentioned they would use included: Making an Action Plan (79%), Physical Activity (80%), Healthy Eating (78%), Decision Making (61%), and Problem Solving (60%). In addition, 96% of the participants either strongly agreed (63%) or agreed (33%) that they were more confident about managing their health conditions after taking PATH. Moreover, 88% of participants said this workshop helped them emotionally and mentally.

Return to top of page

2014 Spirit of Collaboration Awards — Honorable Mention
The Consortium also recognized the efforts of the following organizations with the presentation of 2014 MCC Spirit of Collaboration Honorable Mention Awards for their leadership of exemplary collaborative projects on behalf of the MCC and comprehensive cancer control efforts in Michigan.

    • Harley Men's Health Event
    • Michigan Urological Surgery Improvement Collaborative (MUSIC)